Lactate Use as Triage Tool in Sepsis : Veinous, Capillary or Arterial?

NCT01964690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 103

Last updated 2014-04-29

No results posted yet for this study

Summary

Severe sepsis and septic shocks are increasingly codified. A biomarker as Lactate is very interesting to detect those situations. Usually, lactate used is arterial but results are often too slow to obtain if we want to respect Surviving Sepsis Campaign guidelines. Some analyzers (EKF diagnostics Lactate Scout\*) can give results in 15 seconds.

We hypothesized that capillary lactate, easy to sample, tested with this analyzer may detect earlier those infections states and we want to find the most accurate site to detect severe sepsis (capillary, venous or arterial sample).

Conditions

Sponsors & Collaborators

  • Hopital Saint Roch

    lead OTHER

Principal Investigators

  • Contenti Julie, M.D · Association pour la Formation l'Enseignement et la Recherche du Service de l'Accueil des Urgences

  • Jacques Levraut, PD,MD · CHU de Nice, France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964690 on ClinicalTrials.gov